RNA – avidity biosciences, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

RNA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/13

06:18 am

rna

Avidity Biosciences (RNA) was upgraded by Wells Fargo & Company to "strong-buy".

Medium Report

Avidity Biosciences (RNA) was upgraded by Wells Fargo & Company to "strong-buy".

Report

3/11

09:24 am

rna

Rating for RNA

Low Report

Rating for RNA

Report

3/11

09:24 am

rna

Rating for RNA

Low Report

Rating for RNA

Report

3/11

09:00 am

rna

Avidity Biosciences (RNA) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $25.00 price target on the stock.

Medium Report

Avidity Biosciences (RNA) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $25.00 price target on the stock.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.